Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity-score matched analysis

Am J Hematol. 2021 Dec 1;96(12):E455-E457. doi: 10.1002/ajh.26360. Epub 2021 Oct 4.

Authors

Romil Patel¹, Junsheng Ma², Qaiser Bashir¹, Ruby Delgado¹, Gabriela Rondon¹, Uday R Popat¹, Chitra M Hosing¹, Yago Nieto¹, Partow Kebriaei¹, Amin M Alousi¹, May Daher¹, Rohtesh Mehta¹, Samer Srour¹, Donna M Weber³, Sheeba K Thomas³, Hans C Lee³, Krina K Patel³, Robert Z Orlowski³, Elizabeth S Shpall¹, Richard E Champlin¹, Neeraj Saini¹, Muzaffar H Qazilbash¹

Affiliations

¹ Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
² Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
³ Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

PMID: 34559916
DOI: 10.1002/ajh.26360

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Black People
Hematopoietic Stem Cell Transplantation*
Humans
Multiple Myeloma / epidemiology
Multiple Myeloma / therapy*
Propensity Score
Transplantation, Autologous
Treatment Outcome
White People